Jubilant Organosys Q3 profit rises 74%

BS 200 SCORECARD

Jubilant Organosys has marked a 100 per cent growth in its profit after tax (PAT) during the first nine months of the current financial year as compared with the same period last year. Its corresponding revenues went up by 25 per cent.

The PAT during the third quarter was up by 74 per cent with revenues showing 11 per cent growth.

The third quarter revenues were up at Rs 469 crore as compared with Rs 422 crore during the same period last year.

According to a company release, the pharma and life sciences products (PLSP) business contributed to over 50 per cent of the total revenue for the quarter and showed 27.6 per cent growth.

On a standalone basis, revenues were at Rs 412 crore as against Rs 379 crore during the period, following strong performance in the PLSP business. Revenue growth in the international operations was higher by 23 per cent at Rs 211 crore.

Commenting on the company's financial performance, Shyam S Bhartia, chairman and managing director, Jubilant Organosys, said: "The performance has been driven by our PLSP business, within which CRAMS operations continue to deliver superior results. Our international operations have built a strong foundation and should start active contribution to profits next year onwards. Our outlook, going forward, is very encouraging."

The nine-month net revenues were 25.1 per cent higher at Rs 1,346 crore, with international sales accounting for 45.9 per cent of the business generated in the period at Rs 618 crore (36.1 per cent at Rs 389 crore in the same period of the previous year).

The performance was driven largely by the 49.8 per cent growth in the PLSP products business at Rs 688 crore, the company stated.